In today's edition of Market Checkup, health-care analysts David Williamson and Max Macaluso take a close look at Johnson & Johnson, the largest health-care company in the Dow. They discuss the key takeaways from Johnson & Johnson's second-quarter results and look at its main opportunities in the medical device, pharmaceutical, and consumer health-care spaces.
The Motley Fool's health-care show Market Checkup for August 13, 2013.
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo